Dalriada Celebrates Five Years

Dalriada to Collaborate with atai New Platform Company to Discover Next-Gen Mental Health Therapies

Dalriada Drug Discovery Signs New Agreement with Oxford Cannabinoid Technologies Holdings plc

Dalriada Celebrates Client Dunad Therapeutics Billion Dollar Collaboration with Novartis

Dalriada Congratulates Client Dunad Therapeutics on Billion Dollar Collaboration with Novartis

Dalriada Drug Discovery Collaborates With Antibe Therapeutics to Enable the Rapid Advancement

Dalriada’s Client Dunad Therapeutics just emerged out of Stealth mode, backed by Epidarex Capital

Our Client Janpix Ltd Presents Their Program Updates at the Virtual AACR and EHA Meetings

SilcsBio and Dalriada Launch Partnership to Create a Rapid Drug Discovery Service Suite

Dalriada Welcomes its Newest Client, Champignon Brands

Dalriada Remains Operational During COVID-19: Series of Safety Measures Implemented